Hung Chang

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia

Hung Chang, Ming‐Chung Kuo, Lee‐Yung Shih et al. · European Journal Of Haematology · 2011 · 116 citations

Medicine, Hematology, Hematopathology +16

A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

Hui‐Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung et al. · Scientific Reports · 2017 · 76 citations · Full text

Medicine, Oncology, Pharmacology +13

The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma

Tung‐Liang Lin, Ming‐Chung Kuo, Lee‐Yung Shih et al. · Annals of Hematology · 2012 · 53 citations

Medicine, Geriatric Medicine, Oncology +9